Home › Funds › EUBEL BRADY & SUTTMAN ASSET MANAGEMENT INC › ZBH

EUBEL BRADY & SUTTMAN ASSET MANAGEMENT INC position in ZBH

ZIMMER BIOMET HOLDINGS INC · Health Care

EUBEL BRADY & SUTTMAN ASSET MANAGEMENT INC reported holding 296,529 shares of ZBH (ZIMMER BIOMET HOLDINGS INC) in its Q3 2026 13F filing — a position valued at US$26.3M, representing 3.16% of its reported portfolio and ranking #12 among its reported holdings. EUBEL BRADY & SUTTMAN ASSET MANAGEMENT INC has disclosed ZBH holdings in 13 of the last 13 reported quarters, going back to Q3 2023.

Latest position (Q3 2026)296.53K sh
Reported value held$26.34M
Portfolio Weight3.16%
First reportedQ3 2023
Last changeHold
Updated2026-11-13

Last updated: 2026-11-13 · Source: SEC EDGAR Form 13F-HR

How EUBEL BRADY & SUTTMAN ASSET MANAGEMENT INC's ZBH position evolved

EUBEL BRADY & SUTTMAN ASSET MANAGEMENT INC first disclosed a stake in ZBH in Q3 2023 at 189,691 shares (US$21.3M). The position peaked in Q1 2024 at 223,003 shares, worth US$29.4M. Across 13 filings, EUBEL BRADY & SUTTMAN ASSET MANAGEMENT INC increased the stake 7 time(s), trimmed it 3 time(s) and left it unchanged 2 time(s). The most recent filing (Q3 2026) shows 296,529 shares valued at US$26.3M.

Quarter by quarter

QuarterSharesValueChange
Q3 2023 189.69K $21.29M New
Q4 2023 224.36K $27.30M Add
Q1 2024 223.00K $29.43M Reduce
Q2 2024 229.38K $24.89M Add
Q3 2024 230.33K $24.86M Hold
Q4 2024 233.46K $24.66M Add
Q1 2025 238.06K $26.94M Add
Q2 2025 291.17K $26.56M Add
Q3 2025 292.75K $28.84M Add
Q4 2025 273.48K $24.59M Reduce
Q1 2026 300.09K $27.13M Add
Q2 2026 297.34K $25.60M Reduce
Q3 2026 296.53K $26.34M Hold

Dots on the line are colored by change type; missing quarters mean no position was reported.

About ZBH and 13F data

ZBH (ZIMMER BIOMET HOLDINGS INC) is a Health Care company. 18 other funds we track also report a position in ZBH — the largest reported positions include Dodge & Cox (US$2.08B), DODGE & COX (US$2.08B), Harris Associates (Oakmark) (US$1.10B). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.

Other funds holding ZBH

All ZBH fund holders →

FAQ

How long has EUBEL BRADY & SUTTMAN ASSET MANAGEMENT INC held ZBH?

EUBEL BRADY & SUTTMAN ASSET MANAGEMENT INC has disclosed ZBH holdings in 13 of the last 13 reported quarters, going back to Q3 2023.

What is EUBEL BRADY & SUTTMAN ASSET MANAGEMENT INC's current position in ZBH?

As of Q3 2026, EUBEL BRADY & SUTTMAN ASSET MANAGEMENT INC holds 296.53K shares of ZBH (ZIMMER BIOMET HOLDINGS INC), valued at $26.34M, representing 3.16% of its reported portfolio and ranking #12.

Has EUBEL BRADY & SUTTMAN ASSET MANAGEMENT INC been buying or selling ZBH?

In the latest 13F filing (Q3 2026), EUBEL BRADY & SUTTMAN ASSET MANAGEMENT INC held unchanged its position in ZBH. The position peaked in Q1 2024 at 223.00K shares.

Which other funds hold ZBH?

Other major institutional holders of ZBH include Dodge & Cox, DODGE & COX, Harris Associates (Oakmark), among 18 funds with disclosed positions.

Where does this data come from?

All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.